CYP2D家族基因在大鼠肝癌组织中的表达及突变研究

doi:10.3969/j.issn.1004-616x.2005.03.007

Carcinogenesis, Teratogenesis & Mutagenesis ›› 2005, Vol. 17 ›› Issue (3): 152-155.doi: 10.3969/j.issn.1004-616x.2005.03.007

Previous Articles Next Articles

Expression and Mutation Analysis of CYP2D Subfamily Gene in Rat Hepatocarcinoma

NING Zong;ZHAO Xiao-qin;WANG Nai-ping

The First Affiliated Hospital of Guangxi Medical University,Nanning,530021,Guangxi,China

Received:2004-08-16 Revised:2004-10-12 Online:2005-05-30 Published:2005-05-30
Contact: NING Zong

Abstract

Abstract: BACKGROUND ＆ AIM： To analyze the expressions and their sequences of cytochrome P4502D(CYP2D) subfamily gene in rat heptocarcinoma induced by dimethylaminoazobenzene(DAB). MATERIAL AND METHODS： The rats were induced by azo dye DAB ,the mRNA expression of three isoforms(CYP2D1、CYP2D2 and CYP2D4)were detected by quantitative RT-PCR,then PCR products were sequenced and analyzed. RESULTS: The expression in CYP2D2 and CYP2D4 mRNA decreased dramatically both in hepatocarcinoma and paracancerous tissues(P<0.01),and mRNA of the two isoforms in hepatocarcinoma tissues was lower than in paracancerous tissues(P<0.01). Though CYP2D1 mRNA had a trend of decrease in hepatocarcinoma and paracancerous tissues, no significant difference was found between them. Sequence analysis of those PCR products showed that only a single-site base mutation happened in CYP2D2 from hepatocarcinoma tissues. CONCLUSION: the expression of three isoforms(CYP2D1,CYP2D2 and CYP2D4) mRNA were reduced differently by oza dye DAB, DAB could result in CYP2D2 gene mutation, these indicate that the variants of CYP2D genes may contribute to the progression of hepatocarcinoma. 　　

Key words: dimethylaminoazobenzene, hepatocarcinoma, CYP2D1 gene, CYP2D2 gene, CYP2D4 gene, mutation

NING Zong, ZHAO Xiao-qin, WANG Nai-ping. Expression and Mutation Analysis of CYP2D Subfamily Gene in Rat Hepatocarcinoma[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2005, 17(3): 152-155.

[1]	XU Qilu, GAO Hui, RAN Xuehong, WANG Junjun, ZHANG Junying, LIU Liping. Gene mutation and clinical correlation analyses of myeloid leukemia with abnormal karyotypes [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 296-301,306.
[2]	SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo. Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
[3]	ZHANG Jiahong, ZHANG Qingying, ZHANG Yanhong, CHEN Jialian, XIE Fang, LIU Ruiguo, WU Rong, WU Longfei. Screening and evaluation of gene mutations in a familial hypercholesterolemia family [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 229-232,245.
[4]	CAO Yiyi, LIU Weiying, YOU Xinyue, XI Jing, Chen Ruixue, ZHANG Xinyu, LUAN Yang. In vitro genotoxicity evaluation of BDE-3, BDE-47 and BDE-209 [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 15-20,28.
[5]	ZHENG Kai, WANG Bingyu, XU Xinyun, GENG Hong, HUANG Haiyan, LIU Wei, LONG Dingxin. Mutagenicity of PM_2.5 samples from Shenzhen and Taiyuan [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(6): 483-487.
[6]	YANG Jinru, QIN Lulu, ZHU Yongfei. Meta analysis on association between JAK2 gene mutation and susceptibility to chronic myeloid leukemia [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 231-237.
[7]	LI Ruowan, ZHOU Changhui, HUANG Pengcheng, CHANG Yan. Establishment of an in vitro PIG-A gene mutation assay based on TK6 cells for genotoxicity tests [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 242-248.
[8]	ZHANG Feng, ZHAO Long, FAN Jinping, WU Xueling, MENG Shufang. Induction of tumor in NIH mice by the plasmid containing the V112A and Q61R mutated HRAS [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(1): 1-8.
[9]	SHANG Pingping, HUA Chenfeng, XIE Fuwei, LI Xiang. Mutagenicity of cigarette samples with different tar releases in the TK gene mutation assay [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(1): 49-52.
[10]	WANG Ping, LIU Bingfeng, YANG Yunfeng, CAI Yuwei, TAN Na, YAO Lijuan, LUO Ranran, ZHANG Guo. Mutation frequencies of tumor-related genes in the pancreatic tissues of diet-induced obese mice [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(3): 182-187.
[11]	XIA Ying, FU Shaohua, ZHANG Yinjing, WANG Wei. Genetic toxicity test of a pesticide, Paichongding [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(2): 136-139.
[12]	GUO Xiao, WANG Rui, WU Juan, JI Xiaokun, WANG Heng, ZHANG Yan, MA Yang, DU Yun. Significance of EGFR gene mutation in fresh cytological specimens of lung adenocarcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(1): 67-70.
[13]	CHANG Chen, ZHAO Xiaohan, JIANG Ye, XU Xin, CAI Yan, PEI Yuhui, ZHANG Yu, HAO Jiajie, WANG Mingrong. Identification of predominant genome DNA alterations and their clinical implication in esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(1): 1-6.
[14]	MENG Xiaoqing, FANG Zhijia, WEI Hongyan, YANG Zhanju, HUANG Zhiwei. Genotoxicity investigation of tri- and hexavalent chromium using a yeast SUP4-o mutation assay [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(1): 65-69.
[15]	YUAN Ye, CHEN Dandan, JING Shufang, YU Yongsheng, CHEN Jianheng, WU Chunqi, SHI Chang. Mutagenic effects of N-(n-butyl)-thiophosphorictriamide in somatic and germ cells of mice [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(6): 432-437.

Expression and Mutation Analysis of CYP2D Subfamily Gene in Rat Hepatocarcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments